Celsis Advance - Model II -Rapid Microbial Detection Methods System (RMMs)

Release Safer, Cleaner Products with Celsis^® Rapid Microbial Methods (RMMs)

Rapid microbial detection methods enable users to expose microbial contamination in a matter of hours as opposed to the days required for traditional methods.

By combining a simplified workflow, automated analysis, and an extensive product compatibility portfolio, Celsis^® rapid microbial detection systems optimize the way pharmaceutical and consumer care industries release product safely. Using ATP-based bioluminescence, an industry-proven rapid microbiological method, our instruments provide objective, and, most importantly, confident answer to the question, “Is my product clean or not?"

Building the Business Case for Rapid Microbiology

Traditional quality control testing methods require 3–7 incubation days for bioburden or microbial limits (MLT) and, for sterility, more than 14 days of non-value-add incubation at every point of microbiological testing. This builds unnecessary risk into the production process in the event of a contamination failure, additional inventory storage requirements, product hold times, and delays to market.

In contrast, Celsis^® rapid microbiology delivers results in just 18–24 hours for bioburden and microbial limits and just 6-7 days for sterility testing results, less than half the time of that required by traditional methods. The Celsis rapid microbial detection system provides actionable information at a critical decision point: information that enables you to rapidly confirm the quality of your product, improving your company’s overall profitability, and minimizing risk through:

• Shortened production cycles
• Decreased working capital requirements
• Reduced lab waste to improve sustainability
• Faster response to contamination and shorter investigations
• Reduced inventory requirements and safety stock

By creating a more streamlined, responsive, and lean manufacturing process, Celsis^® rapid microbial detection drives supply chain efficiencies, reduces contamination response and investigation times, and maximizes production and testing throughput. Available in multiple sizes to suit every business need and industry, rapid microbial detection systems will transform the way you do business.

The Celsis Advance II™ system is designed to deliver definitive micro results quickly, so Pharmaceutical and Home & Beauty manufacturers can cut days off their production cycles and reduce working capital requirements.

Rapid Microbial Contamination Screening for QC Micro Testing

For 20 years, Celsis^® systems have helped companies worldwide screen products for microbial contamination. With installations in more than 65 countries and a global network of service and support partners, Celsis^® is uniquely qualified to work with companies of all sizes that want to reduce the delays and associated costs of lengthy micro hold times.

The Celsis Advance II™ system brings added functionality and even greater ease-of-use features, including:

• Broader access to data
• More comprehensive data analysis and trend reporting
• Enhanced system security
• A fourth injector option

This system has been designed to run the same protocols and generate the same results as the current Advance system. There is no product revalidation required for sites upgrading from the older Advance platform. Installation Qualification and Operational Qualification protocols have been developed to seamlessly manage system transfers.

• Celsis Advance II™ System Features
• Advance.im™ Software Features
• Specifications